Market Overview:
The global hydroxychloroquine drug market is expected to grow at a CAGR of XX% during the forecast period from 2018 to 2030. The market growth can be attributed to factors such as the increasing prevalence of malaria, rheumatoid arthritis, COVID-19, systemic lupus erythematosus and other diseases; and the growing demand for hydroxychloroquine drugs in hospital pharmacies, retail pharmacies and online pharmacies. However, the high cost of hydroxychloroquine drugs may restrain the growth of this market during the forecast period.
Product Definition:
hydroxychloroquine (hī´drŏk´sēklōrō´kwīn) , a synthetic 4-aminoquinoline derivative, is an antimalarial agent used in the treatment of malaria, lupus erythematosus, rheumatoid arthritis, and other autoimmune disorders. It is also effective in the prevention of malaria. Hydroxychloroquine is taken orally and may be given with or without food. The usual adult dosage for treating lupus erythematosus or rheumatoid arthritis is 400 mg once or twice daily. For preventing malaria it may be given as 200 mg once weekly starting 1 week before travel to an area where malaria occurs and continued for 4 weeks after leaving the area. Side effects are rare but include headache, dizziness, blurred vision, nausea, vomiting, diarrhea.
Malaria:
Hydroxychloroquine, also known as hydroxychloroquine sulfate or hydroxychloroquine, is an immunosuppressive drug with anti-viral properties. It was first synthesized in the early 1950s and has been used to treat diseases caused by viruses and bacteria. Malaria is one such disease that can be treated using this drug; hence it has gained popularity over the years.
Rheumatoid Arthritis:
Rheumatoid arthritis (RA) is a chronic disorder characterized by joint inflammation. It most commonly affects the hands, feet, and wrist; however, it can affect any part of the body. The cause of this disease is still unknown and there’s no single factor that can be attributed to its cause.
Application Insights:
The global market is categorized into hospital pharmacies, retail pharmacies, and online pharmacies. The hospital pharmacy segment dominated the market in 2017 due to factors such as high product volume usage for the treatment of malaria and rheumatoid arthritis. In addition, increasing R&D activities by various manufacturers are expected to drive demand from hospital pharmacy segments over the forecast period.
The retail pharmacy segment is anticipated to witness significant growth during the study period owing to growing awareness about health issues among consumers coupled with rising healthcare expenditure levels in developing countries such as India and China. Rising investments by governments in improving public healthcare infrastructure are also likely to play a key role in driving hydroxychloroquine drug consumption at retail pharmacies over the forecast period.
Online pharmacies are expected to emerge as a lucrative opportunity for industry participants during the forecast years due largely demographic changes that have taken place across most regions of Europe.
Regional Analysis:
North America was the largest market for hydroxychloroquine drugs accounting for a share of more than 40.0% in 2017. The region is expected to maintain its dominance over the forecast period as well owing to increasing prevalence of rheumatoid arthritis and malaria in U.S., which has led to an increase in demand for Hydroxychloroquine Tablets & Capsules, Malarone, and Plaquenil Tablets & Capsules respectively.
Asia Pacific is estimated to be one of the fastest-growing regions with a CAGR 6.4% from 2018 to 2030 due rising hydroxychloroquine drug affordability coupled with high unmet medical needs pertaining especially towards malaria eradication programs across countries such as India.
Growth Factors:
- Increasing prevalence of autoimmune diseases: Hydroxychloroquine Drug is used to treat a wide range of autoimmune diseases such as rheumatoid arthritis, systemic lupus erythematosus (SLE), and Sjögren's syndrome. The global prevalence of autoimmune diseases is increasing, which is expected to drive the demand for Hydroxychloroquine Drug in the coming years.
- Rising awareness about hydroxychloroquine drug: There is a growing awareness among healthcare professionals and patients about the benefits of hydroxychloroquine drug therapy for treating various autoimmune diseases. This is likely to boost the demand for hydroxychloroquine drugs in the near future.
- Growing number of clinical studies on hydroxychloroquine: A large number of clinical studies are being conducted on hydroxychloroquine drug therapy for various indications such as rheumatoid arthritis, SLE, and psoriasis vulgaris. This is likely to create greater awareness about its potential benefits among healthcare professionals and patients, which will spur demand for this drug in the coming years.
Scope Of The Report
Report Attributes
Report Details
Report Title
Hydroxychloroquine Drug Market Research Report
By Type
Malaria, Rheumatoid Arthritis, COVID-19, Systemic Lupus Erythematosus, Others
By Application
Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
By Companies
Sanofi, Amneal Pharmaceuticals, Mylan, Teva Pharmaceutical, Novartis, Zydus Cadila, Dr. Reddy’s Laboratories, Sun Pharmaceutical, Lupin Limited, Prasco Laboratories
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
154
Number of Tables & Figures
108
Customization Available
Yes, the report can be customized as per your need.
Global Hydroxychloroquine Drug Market Report Segments:
The global Hydroxychloroquine Drug market is segmented on the basis of:
Types
Malaria, Rheumatoid Arthritis, COVID-19, Systemic Lupus Erythematosus, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Sanofi
- Amneal Pharmaceuticals
- Mylan
- Teva Pharmaceutical
- Novartis
- Zydus Cadila
- Dr. Reddy’s Laboratories
- Sun Pharmaceutical
- Lupin Limited
- Prasco Laboratories
Highlights of The Hydroxychloroquine Drug Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Malaria
- Rheumatoid Arthritis
- COVID-19
- Systemic Lupus Erythematosus
- Others
- By Application:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Hydroxychloroquine Drug Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Hydroxychloroquine is a medication used to treat malaria. It works by stopping the growth of the parasite in your body.
Some of the major companies in the hydroxychloroquine drug market are Sanofi, Amneal Pharmaceuticals, Mylan, Teva Pharmaceutical, Novartis, Zydus Cadila, Dr. Reddy’s Laboratories, Sun Pharmaceutical, Lupin Limited, Prasco Laboratories.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Hydroxychloroquine Drug Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Hydroxychloroquine Drug Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Hydroxychloroquine Drug Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Hydroxychloroquine Drug Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Hydroxychloroquine Drug Market Size & Forecast, 2020-2028
4.5.1 Hydroxychloroquine Drug Market Size and Y-o-Y Growth
4.5.2 Hydroxychloroquine Drug Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Malaria
5.2.2 Rheumatoid Arthritis
5.2.3 COVID-19
5.2.4 Systemic Lupus Erythematosus
5.2.5 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospital Pharmacies
6.2.2 Retail Pharmacies
6.2.3 Online Pharmacies
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Hydroxychloroquine Drug Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Hydroxychloroquine Drug Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Malaria
9.6.2 Rheumatoid Arthritis
9.6.3 COVID-19
9.6.4 Systemic Lupus Erythematosus
9.6.5 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospital Pharmacies
9.10.2 Retail Pharmacies
9.10.3 Online Pharmacies
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Malaria
10.6.2 Rheumatoid Arthritis
10.6.3 COVID-19
10.6.4 Systemic Lupus Erythematosus
10.6.5 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospital Pharmacies
10.10.2 Retail Pharmacies
10.10.3 Online Pharmacies
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Malaria
11.6.2 Rheumatoid Arthritis
11.6.3 COVID-19
11.6.4 Systemic Lupus Erythematosus
11.6.5 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospital Pharmacies
11.10.2 Retail Pharmacies
11.10.3 Online Pharmacies
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Malaria
12.6.2 Rheumatoid Arthritis
12.6.3 COVID-19
12.6.4 Systemic Lupus Erythematosus
12.6.5 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospital Pharmacies
12.10.2 Retail Pharmacies
12.10.3 Online Pharmacies
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Malaria
13.6.2 Rheumatoid Arthritis
13.6.3 COVID-19
13.6.4 Systemic Lupus Erythematosus
13.6.5 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospital Pharmacies
13.10.2 Retail Pharmacies
13.10.3 Online Pharmacies
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Hydroxychloroquine Drug Market: Competitive Dashboard
14.2 Global Hydroxychloroquine Drug Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Sanofi
14.3.2 Amneal Pharmaceuticals
14.3.3 Mylan
14.3.4 Teva Pharmaceutical
14.3.5 Novartis
14.3.6 Zydus Cadila
14.3.7 Dr. Reddy’s Laboratories
14.3.8 Sun Pharmaceutical
14.3.9 Lupin Limited
14.3.10 Prasco Laboratories
